SUBMIT YOUR ORIGINAL RESEARCH TO ANR2018 IN SAN FRANCISCO!
The scientific organizers welcome the submission of original Neuroblastoma research for presentation at ANR2018 in San Francisco. The biennial Advances in Neuroblastoma Research Congress is the leading international forum for sharing the most recent advances in basic, translational and clinical Neuroblastoma research.
ANR welcomes the submission of abstracts on the topics listed below. To facilitate the review process, three abstract categories have been developed for ANR2018, and the submission site will open in the Fall of 2017.
MYCN/MYC ALK RAS Telomerase/telomeres Other critical pathways Genetics and epigenetics Genome-wide analysis Genomic instabiility/DNA repair Non-coding RNA Chromatin modification Transcription Translation control/mrna Developmental biology Tumor initiaton and cancer stem cells Metastasis Apoptosis/cell death Immunology/TME
Early phase clinical trials Novel targeted therapy in development (clinical) Immunotherapy Clinical trial biomarker development and design Imaging and diagnostics Radiation therapy Nuclear medicine Nursing related topics Trials in countries with limited resources Surgery Survivorship and late effects
Abstract submission site opens in the Fall of 2017!